New Drug Submission for Abraxane Filed in Canada

American Pharmaceutical Partners has filed a new drug Submission for Abraxane with the Therapeutic Products Directorate of Health Canada.

The submission seeks Health Canada's approval to market Abraxane in Canada for the treatment of metastatic breast cancer.